UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
International journal of immunopathology and pharmacology, ISSN 2058-7384, 3/2017, Volume 30, Issue 1, pp. 73 - 82
immunoglobulin replacement | primary immunodeficiency | intravenous immunoglobulins | therapy satisfaction | subcutaneous immunoglobulins | Pharmacology & Pharmacy | Pathology | Immunology | Life Sciences & Biomedicine | Science & Technology | Immunoglobulin G - blood | Humans | Middle Aged | Immunoglobulin G - therapeutic use | Immunoglobulins, Intravenous - administration & dosage | Male | Immunoglobulins - administration & dosage | Immunoglobulin G - administration & dosage | Young Adult | Administration, Intravenous | Immunoglobulins, Intravenous - therapeutic use | Injections, Subcutaneous | Adolescent | Adult | Female | Immunologic Deficiency Syndromes - blood | Aged | Immunologic Deficiency Syndromes - drug therapy | Immunoglobulins - therapeutic use | Child | Immunoglobulins | Immunoglobulin G | Intravenous administration | Index Medicus | Letters to the Editor
Journal Article
Cochrane library, ISSN 1469-493X, 2014, Volume 2019, Issue 10, pp. CD002063 - CD002063
Guillain‐Barre Syndrome | Neurology | Intravenous immunoglobulin treatment | Child health | Guillain‐Barré syndrome | Plasma Exchange | Medicine General & Introductory Medical Sciences | Peripheral neuropathy | Immunoglobulins, Intravenous | Recovery of Function | Randomized Controlled Trials as Topic | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Guillain-Barre Syndrome - therapy | Guillain-Barre Syndrome - immunology | Immunoglobulins, Intravenous - therapeutic use | Humans | Immunoglobulins, Intravenous - adverse effects | Adult | Plasma Exchange - adverse effects | Outcome Assessment, Health Care | Child | Index Medicus
Journal Article
Clinical and experimental immunology, ISSN 0009-9104, 12/2015, Volume 182, Issue 3, pp. 302 - 313
subcutaneous immunoglobulin (SCIg) | facilitated subcutaneous immunoglobulin (fSCIg) | hyaluronidase | intravenous immunoglobulin (IVIg) | primary immunodeficiency (PID) | Hyaluronidase | Subcutaneous immunoglobulin (SCIg) | Intravenous immunoglobulin (IVIg) | Primary immunodeficiency (PID) | Facilitated subcutaneous immunoglobulin (fSCIg) | Life Sciences & Biomedicine | Immunology | Science & Technology | Education, Medical, Continuing | Follow-Up Studies | Humans | Injections, Subcutaneous | Immunoglobulins - adverse effects | Female | Male | Immunologic Deficiency Syndromes - drug therapy | Immunoglobulins - administration & dosage | Ultrasound imaging | Immunoglobulins | Immunodeficiency | Patients | Index Medicus | Original
Journal Article
1995, ISBN 1871816297, vii, 88
Book
Journal of molecular biology, ISSN 0022-2836, 09/2014, Volume 426, Issue 18, pp. 3166 - 3179
X-ray crystallography | IVIG | inflammation | sialylated IgG Fc | N-linked glycan | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Immunoglobulin G - isolation & purification | Immunoglobulin Fc Fragments - metabolism | Humans | Crystallography, X-Ray | Anti-Inflammatory Agents - metabolism | Immunoglobulins, Intravenous - metabolism | Anti-Inflammatory Agents - isolation & purification | Protein Structure, Tertiary | Cell Line | Immunoglobulins, Intravenous - isolation & purification | Immunoglobulin G - chemistry | Sialic Acids - metabolism | Models, Molecular | Immunoglobulin Fc Fragments - chemistry | Glycosylation | Immunoglobulins, Intravenous - genetics | Polysaccharides - metabolism | Immunoglobulin Fc Fragments - isolation & purification | Anti-Inflammatory Agents - chemistry | Immunoglobulin G - genetics | Antigens - immunology | Immunoglobulins, Intravenous - chemistry | Mutation | Immunoglobulin Fc Fragments - genetics | Immunoglobulin G - metabolism | Polysaccharides | Anti-inflammatory drugs | Analysis | Immunoglobulin G | Crystals | Chemical properties | Structure | Antigens | Mass spectrometry | Index Medicus
Journal Article
Vox sanguinis, ISSN 0042-9007, 04/2019, Volume 114, Issue 3, pp. 237 - 246
malignancy | cost–utility analysis | secondary immunodeficiency | intravenous immunoglobulin | subcutaneous immunoglobulin | health economics | Life Sciences & Biomedicine | Hematology | Science & Technology | Hospital Costs | Immunization, Passive - economics | Immunologic Deficiency Syndromes - therapy | Immunoglobulins, Intravenous - economics | Immunoglobulins, Intravenous - therapeutic use | Cost-Benefit Analysis | Humans | Immunoglobulins, Intravenous - administration & dosage | Female | Male | Australia | Medical care | Analysis | Immunodeficiency | Medical care, Cost of | Quality management | Health care | Immunoglobulins | Sensitivity analysis | Intravenous administration | Computer simulation | Medical treatment | Markov chains | Parameter sensitivity | Cost analysis | Patients | Cost control
Journal Article
Transfusion (Philadelphia, Pa.), ISSN 0041-1132, 12/2017, Volume 57, Issue 12, pp. 3019 - 3025
Life Sciences & Biomedicine | Hematology | Science & Technology | Immunoglobulins, Intravenous - therapeutic use | Humans | Adolescent | Egypt | Child, Preschool | Immunoglobulins, Intravenous - administration & dosage | Female | Infant | Male | Treatment Outcome | Child | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Thrombocytopenia | Immunoglobulin G | Pathogens | Immunoglobulins | Intravenous administration | Effectiveness | Parents | Idiopathic thrombocytopenic purpura | Patients | Bleeding | Side effects | Randomization | Informed consent | Children | Safety | Platelets | Blood groups | Index Medicus
Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 4/2008, Volume 320, Issue 5874, pp. 373 - 376
Fc receptors | Polysaccharides | Immunoglobulins | Antiinflammatories | Lectins | Antibodies | Cytotoxicity | Recapitulation theory | Idiopathic thrombocytopenic purpura | Reports | Post hoc | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Fundamental and applied biological sciences. Psychology | Biotechnology | Health. Pharmaceutical industry | Industrial applications and implications. Economical aspects | Other active biomolecules | Biological and medical sciences | Production of active biomolecules | Recombinant Proteins - therapeutic use | Arthritis, Experimental - drug therapy | Immunoglobulin Fc Fragments - metabolism | Humans | Receptors, Fc - metabolism | Immunoglobulins, Intravenous - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Immunoglobulin Fc Fragments - administration & dosage | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Polysaccharides - chemistry | Immunoglobulin Fc Fragments - therapeutic use | Autoimmune Diseases - drug therapy | Immunoglobulin G - chemistry | Mice, Inbred C57BL | Immunoglobulin G - therapeutic use | Recombinant Proteins - chemistry | Immunoglobulin Fc Fragments - chemistry | Glycosylation | Immunoglobulin G - administration & dosage | N-Acetylneuraminic Acid - chemistry | Galactose - chemistry | Animals | Immunoglobulins, Intravenous - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Mice, Inbred NOD | Immunoglobulins, Intravenous - chemistry | Mice | Carbohydrate Conformation | Immunoglobulin G - metabolism | Influence | Anti-inflammatory drugs | Properties | Recombinant molecules | Immunoglobulin G | Biochemistry | Immunology | Drug therapy | Autoimmune diseases | Immune system | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 379, Issue 9826, pp. 1613 - 1620
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Prevention and actions | Biological and medical sciences | Medical sciences | Mucocutaneous Lymph Node Syndrome - drug therapy | Prospective Studies | Humans | Coronary Artery Disease - prevention & control | Child, Preschool | Infant | Male | Anti-Inflammatory Agents - therapeutic use | Female | Aspirin - therapeutic use | Prednisolone - therapeutic use | Drug Therapy, Combination | Immunoglobulins - therapeutic use | Coronary Vessel Anomalies - prevention & control | Complications and side effects | Kawasaki disease | Dosage and administration | Drug therapy | Coronary heart disease | Risk factors | Prednisolone | Clinical trials | Immunoglobulins | Disease | Medical treatment | Metabolic disorders | Index Medicus | Abridged Index Medicus | Corticoids | Aspirin | C-reactive protein | Intravenous administration | coronary artery | Thrombosis | Cholesterol | Proteins | Side effects | Hospitals | Motivation | Mucocutaneous lymph node syndrome | prevention | Neutropenia
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2016, Volume 139, Issue 3, pp. S1 - S46